Barclays PLC Grows Stock Holdings in The Pennant Group, Inc. (NASDAQ:PNTG)

Barclays PLC boosted its stake in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 22.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 60,070 shares of the company's stock after purchasing an additional 10,969 shares during the quarter. Barclays PLC owned about 0.17% of The Pennant Group worth $1,593,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Van Berkom & Associates Inc. increased its position in shares of The Pennant Group by 2,635.6% during the fourth quarter. Van Berkom & Associates Inc. now owns 2,198,216 shares of the company's stock worth $58,297,000 after acquiring an additional 2,117,859 shares in the last quarter. FMR LLC grew its holdings in The Pennant Group by 54.5% during the fourth quarter. FMR LLC now owns 3,906,327 shares of the company's stock valued at $103,596,000 after purchasing an additional 1,377,815 shares during the period. Vanguard Group Inc. increased its holdings in The Pennant Group by 11.0% in the 4th quarter. Vanguard Group Inc. now owns 2,261,564 shares of the company's stock worth $59,977,000 after acquiring an additional 223,919 shares during the last quarter. Ranger Investment Management L.P. raised its position in shares of The Pennant Group by 147.3% in the fourth quarter. Ranger Investment Management L.P. now owns 195,210 shares of the company's stock valued at $5,177,000 after purchasing an additional 116,285 shares during the period. Finally, Raymond James Financial Inc. bought a new stake in The Pennant Group during the 4th quarter valued at $2,570,000. 85.88% of the stock is owned by institutional investors.

The Pennant Group Trading Down 0.5 %

PNTG traded down $0.13 during trading on Thursday, hitting $27.63. 6,099 shares of the stock traded hands, compared to its average volume of 224,431. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12. The firm has a market capitalization of $959.37 million, a P/E ratio of 40.63, a price-to-earnings-growth ratio of 2.24 and a beta of 1.56. The Pennant Group, Inc. has a 12-month low of $20.91 and a 12-month high of $37.13. The firm has a 50-day moving average of $24.81 and a 200 day moving average of $27.48.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on PNTG. Stephens reissued an "overweight" rating and issued a $38.00 price target on shares of The Pennant Group in a report on Wednesday, April 2nd. Truist Financial reduced their price objective on The Pennant Group from $32.00 to $28.00 and set a "hold" rating on the stock in a research report on Friday, March 7th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, The Pennant Group has a consensus rating of "Moderate Buy" and a consensus price target of $34.80.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.